NFATc1信号驱动慢性内质网应激反应促进非酒精性脂肪性肝病进展
研究探讨NFATc1在非酒精性脂肪性肝病(NAFLD)进展中的作用机制。在患者肝脏、原代及培养肝细胞和肝细胞特异性转基因小鼠中检测NFATc1激活与调控,动物接受高脂西方饮食单独或联合牛磺熊去氧胆酸(TUDCA)喂养。结果显示NFATc1在晚期NAFLD中强诱导并与肝酶、炎症和纤维化相关,通过PERK-CHOP未折叠蛋白反应驱动肝细胞损伤和炎症,TUDCA可阻断NFATc1诱导的向脂肪性肝炎进展。
要点
- NFATc1在健康肝脏中表达弱,在晚期NAFLD阶段强烈诱导并与肝酶、肝脏炎症和纤维化相关。
- 高脂西方饮食增加NFATc1表达、核定位和激活以促进NAFLD进展,肝细胞特异性缺失可防止疾病加速。
- NFATc1通过内质网应激感知和PERK-CHOP未折叠蛋白反应驱动肝细胞损伤和炎症,TUDCA可阻断其诱导的向脂肪性肝炎进展。
核心结论
- NFATc1通过慢性内质网应激感知及随后激活肝细胞终末未折叠蛋白反应信号促进NAFLD进展。
- 干扰内质网应激反应(例如通过TUDCA)可保护脂肪肝免于向明显脂肪性肝炎进展。
研究设计与样本
- 在NAFLD患者肝脏、培养和原代肝细胞以及肝细胞特异性差异表达该转录因子的转基因小鼠(Alb-cre、NFATc1c.a.和NFATc1Δ/Δ)中检测NFATc1激活与调控。
- 动物接受高脂西方饮食单独或联合TUDCA(NAFLD治疗的候选药物)喂养,在体外和体内评估NFATc1依赖性内质网应激反应、NLRP3炎症小体激活和疾病进展。
主要发现
- NFATc1在健康肝脏中表达弱,但在晚期NAFLD阶段强烈诱导,与肝酶值以及肝脏炎症和纤维化相关。
- 高脂西方饮食增加NFATc1表达、核定位和激活以促进NAFLD进展,而肝细胞特异性缺失该转录因子可防止小鼠疾病加速。
- NFATc1通过内质网应激感知和激活PERK-CHOP未折叠蛋白反应驱动肝细胞损伤和炎症。
- NFATc1诱导的向脂肪性肝炎疾病进展可被TUDCA给药阻断。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) can persist in the stage of simple hepatic steatosis or progress to steatohepatitis (NASH) with an increased risk for cirrhosis and cancer. We examined the mechanisms controlling the progression to severe NASH in order to develop future treatment strategies for this disease. DESIGN: NFATc1 activation and regulation was examined in livers from patients with NAFLD, cultured and primary hepatocytes and in transgenic mice with differential hepatocyte-specific expression of the transcription factor (Alb-cre, NFATc1c.a . and NFATc1Δ/Δ ). Animals were fed with high-fat western diet (WD) alone or in combination with tauroursodeoxycholic acid (TUDCA), a candidate drug for NAFLD treatment. NFATc1-dependent ER stress-responses, NLRP3 inflammasome activation and disease progression were assessed both in vitro and in vivo. RESULTS: NFATc1 expression was weak in healthy livers but strongly induced in advanced NAFLD stages, where it correlates with liver enzyme values as well as hepatic inflammation and fibrosis. Moreover, high-fat WD increased NFATc1 expression, nuclear localisation and activation to promote NAFLD progression, whereas hepatocyte-specific depletion of the transcription factor can prevent mice from disease acceleration. Mechanistically, NFATc1 drives liver cell damage and inflammation through ER stress sensing and activation of the PERK-CHOP unfolded protein response (UPR). Finally, NFATc1-induced disease progression towards NASH can be blocked by TUDCA administration. CONCLUSION: NFATc1 stimulates NAFLD progression through chronic ER stress sensing and subsequent activation of terminal UPR signalling in hepatocytes. Interfering with ER stress-responses, for example, by TUDCA, protects fatty livers from progression towards manifest NASH.
引用
- Latif MU, Schmidt GE, Mercan S, et al. NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression. Gut. 2022. PMID: 35365570. doi:10.1136/gutjnl-2021-325013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。